Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Alpha Blockers (Terazosin vs Tamsulosin) in Reducing Ureteral Stent Related Symptoms - An Open-label, Randomized Controlled Trial

NCT06966804 is registered in ClinicalTrials.gov with Penang Hospital, Malaysia as lead sponsor.

NCT NCT06966804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06966804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Alpha Blockers (Terazosin vs Tamsulosin) in Reducing Ureteral Stent Related Symptoms - An Open-label, Randomized Controlled Trial
Lead sponsor
Penang Hospital, Malaysia
Phase
Phase 3
Overall status
Recruiting
Start date
June 1, 2025
Completion date
July 31, 2027
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stent related symptoms